Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04807179 · ClinicalTrials.gov registry record · NA
Clinical Study to Evaluate Alexandrite Laser for the Treatment of Acne Scars
A NA study of Acne Scars, sponsored by Cynosure.
- Active
- Registry status
- NA
- Development phase
- 39
- Enrollment target
- 2
- Study locations
NCT04807179: Active NA study of Acne Scars, sponsored by Cynosure.
NCT04807179 is a NA study of Acne Scars that is active but no longer recruiting, run by Cynosure. The registered enrollment target is 39 participants, below the 80-participant average among 6 other Acne Scars trials with a reported enrollment target (51% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04807179, a NA study of Acne Scars, is active but no longer recruiting, sponsored by Cynosure.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
- 2
- Study locations
Study Summary
The intended use of the Alexandrite laser device used in this study is to assess the efficacy and safety of the Alexandrite laser device for the treatment of acne scars on skin types V and VI.
Conditions Studied
Interventions
- DEVICE Experimental: RF Device Arm
Study Locations (2)
California
- Wallace Skin and Body Institute - Los Angeles
New York
- Laser & Skin Surgery Center of New York - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2021-03-08 |
| Est. Completion | 2024-08-02 |
| Phase | NA |
What the registry record for NCT04807179 still lists
NCT04807179 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 80-participant average among 6 other Acne Scars trials with a reported enrollment target (51% lower).
The record links to 1 condition, with Acne Scars appearing as the primary indexed condition, and to 1 intervention - of which Experimental: RF Device Arm is the first listed.
NCT04807179 reports a single indexed study location in California, New York.
Frequently Asked Questions
What is clinical trial NCT04807179 about?
NCT04807179 is a clinical study titled "Clinical Study to Evaluate Alexandrite Laser for the Treatment of Acne Scars". The intended use of the Alexandrite laser device used in this study is to assess the efficacy and safety of the Alexandrite laser device for the treatment of acne scars on skin types V and VI.
What is the current status of trial NCT04807179?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 39 participants. The study started on 2021-03-08. Estimated completion is 2024-08-02.
What conditions does trial NCT04807179 study?
This clinical trial studies the following conditions: Acne Scars.
What interventions are being tested in trial NCT04807179?
The interventions under investigation include: Experimental: RF Device Arm (DEVICE).
Who is sponsoring clinical trial NCT04807179?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04807179 being conducted?
This trial has 2 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne Scars
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions
RECRUITING · NA
-
Effect of Subcision and Suction on Acne Scars
ACTIVE NOT RECRUITING · NA
-
Effect of Multiple Subcisions on Rolling Acne Scars
ACTIVE NOT RECRUITING · NA
-
Post Market Usability Evaluation Of The PicoSure Pro Device
COMPLETED · NA
-
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
RECRUITING · Phase 3
-
Comparison of Stacked-Pulses Vs. Double-Pass Treatments of Facial Acne With a 1450 Nm Laser
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI